应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01521 方达控股
停牌 11-06 09:20:42
1.490
+0.000
0.00%
最高
1.490
最低
1.490
成交量
0.00
今开
1.490
昨收
1.490
日振幅
0.00%
总市值
30.43亿
流通市值
30.43亿
总股本
20.42亿
成交额
0.00
换手率
0.00%
流通股本
20.42亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
方达控股10月股份变动月报表:股本小幅减少
公告速递 · 11-04
方达控股10月股份变动月报表:股本小幅减少
方达控股(01521)2026年前三季度收入2.31亿美元 同比增长20.9%
公告速递 · 10-29
方达控股(01521)2026年前三季度收入2.31亿美元 同比增长20.9%
方达控股(01521)前三季度取得纯利约1190万美元 同比增加113.1%
智通财经 · 10-29
方达控股(01521)前三季度取得纯利约1190万美元 同比增加113.1%
泰格医药(300347.SZ)控股子公司方达控股(01521)停牌
智通财经 · 10-22
泰格医药(300347.SZ)控股子公司方达控股(01521)停牌
方达控股(01521)10月22日起短暂停牌 待刊发收购及合并守则相关内幕消息
公告速递 · 10-22
方达控股(01521)10月22日起短暂停牌 待刊发收购及合并守则相关内幕消息
方达控股(01521.HK)10月22日起短暂停牌
智通财经 · 10-22
方达控股(01521.HK)10月22日起短暂停牌
方达控股(01521)10月22日起短暂停牌
智通财经 · 10-22
方达控股(01521)10月22日起短暂停牌
泰格医药(03347):方达控股10月22日起短暂停牌 待刊发内幕消息
智通财经 · 10-22
泰格医药(03347):方达控股10月22日起短暂停牌 待刊发内幕消息
港股直击|医药股及医药外包股续上扬,方达控股升 7%,歌礼制药、云顶新耀、金斯瑞生物升6%
老虎资讯综合 · 10-21
港股直击|医药股及医药外包股续上扬,方达控股升 7%,歌礼制药、云顶新耀、金斯瑞生物升6%
港股直击|医药股及医药外包股上扬,方达控股升9%,昭衍新药升7%,康诺亚、华领医药升4%
老虎资讯综合 · 10-20
港股直击|医药股及医药外包股上扬,方达控股升9%,昭衍新药升7%,康诺亚、华领医药升4%
方达控股2026年9月股本结构保持稳定,未现新增发行
公告速递 · 10-06
方达控股2026年9月股本结构保持稳定,未现新增发行
方达控股2026年中期营收1.48亿美元,经调整净利润0.13亿美元
公告速递 · 09-22
方达控股2026年中期营收1.48亿美元,经调整净利润0.13亿美元
方达控股更新8月股份变动月报表,股本维持稳定
公告速递 · 09-04
方达控股更新8月股份变动月报表,股本维持稳定
方达控股(01521.HK)发布中期业绩 股东应占溢利675.5万美元 同比增加130.78%
智通财经 · 08-28
方达控股(01521.HK)发布中期业绩 股东应占溢利675.5万美元 同比增加130.78%
方达控股:上半财年净利润同比增长134.50%
南方财经网 · 08-28
方达控股:上半财年净利润同比增长134.50%
方达控股(01521)2026年上半年营收1.48亿美元,经调整净利润13.4百万美元
公告速递 · 08-28
方达控股(01521)2026年上半年营收1.48亿美元,经调整净利润13.4百万美元
CXO概念有支撑 凯莱英(06821)涨2.27% 金斯瑞生物科技(01548)涨2.41%
金吾财讯 · 08-19
CXO概念有支撑 凯莱英(06821)涨2.27% 金斯瑞生物科技(01548)涨2.41%
方达控股(01521)拟于8月28日召开董事会审议2026年中期业绩及派息事宜
公告速递 · 08-17
方达控股(01521)拟于8月28日召开董事会审议2026年中期业绩及派息事宜
方达控股更新2026年6月股份变动月报表:总股本增至2,042,074,910股
公告速递 · 08-12
方达控股更新2026年6月股份变动月报表:总股本增至2,042,074,910股
医药外包概念股集体扬升 药明生物(02269)涨4.36% 机构指行业景气度上行信号明确
金吾财讯 · 08-10
医药外包概念股集体扬升 药明生物(02269)涨4.36% 机构指行业景气度上行信号明确
加载更多
公司概况
公司名称:
方达控股
所属市场:
SEHK
上市日期:
--
主营业务:
Frontage Holdings Corp是一家控股公司。该公司为制药和农用化学品公司提供实验室和相关服务,以及生物等效性临床和化学服务。该公司有两个分部。全球实验室服务部门为参与药物开发的客户提供实验室测试支持。全球药物发现与开发服务部门包括药物开发部门、药物发现部门和药品开发部门。其全球实验室服务涵盖受监管和非受监管的生物分析(小分子和大分子)、生物标志物、基因组学、制造和控制分析测试以及中央实验室服务。药物开发部门包括药物代谢和药代动力学、安全性和毒理学。该公司的业务分部包括北美和欧洲以及中国。
发行价格:
--
{"stockData":{"symbol":"01521","market":"HK","secType":"STK","nameCN":"方达控股","latestPrice":1.49,"timestamp":1793928042753,"preClose":1.49,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":2042000000,"shares":2042000000,"eps":0.0033,"marketStatus":"停牌","change":0,"latestTime":"11-06 09:20:42","open":1.49,"high":1.49,"low":1.49,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.040787,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794187800000},"marketStatusCode":7,"adr":0,"listingDate":1559145600000,"exchange":"SEHK","adjPreClose":1.49,"openAndCloseTimeList":[[1793928600000,1793937600000],[1793941200000,1793952000000]],"volumeRatio":3.354747727879826,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01521","defaultTab":"news","newsList":[{"id":"1198981549","title":"方达控股10月股份变动月报表:股本小幅减少","url":"https://stock-news.laohu8.com/highlight/detail?id=1198981549","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1198981549?lang=zh_cn&edition=full","pubTime":"2026-11-04 16:39","pubTimestamp":1793781567,"startTime":"0","endTime":"0","summary":"方达控股公司于2026年11月4日公布截至2026年10月31日止月份的股份变动月报表。报告期内,公司注册股本保持不变,仍为5,000,000,000股普通股,每股面值为0.00001美元,合计注册股本50,000美元。公司于本月末的已发行股份由上月底的2,042,074,910股减少至2,038,538,910股,净减少3,536,000股,主要原因为当月进行了回购并注销的股份合计3,536,000股。本期内未因期权行使产生新的已发行股份,也未有新的资金流入。截至本月末,方达控股已发行股份总数为2,038,538,910股。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161020810","title":"方达控股(01521)2026年前三季度收入2.31亿美元 同比增长20.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1161020810","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161020810?lang=zh_cn&edition=full","pubTime":"2026-10-29 16:37","pubTimestamp":1793263047,"startTime":"0","endTime":"0","summary":"方达控股10月29日在港交所公告,截至2026年9月30日止九个月未经审计的综合收益约为2.31亿美元,较2025年同期增加20.9%。同期,本集团录得未经审计纯利约1,190万美元,同比上升113.1%。扣除以股份为基础的薪酬开支、并购所得无形资产摊销、按公允价值计入损益计量的金融资产所产生的收益或亏损、重组及资源整合举措产生的亏损及并购相关开支后,经调整纯利约2,060万美元,同比增幅为62.7%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679478272","title":"方达控股(01521)前三季度取得纯利约1190万美元 同比增加113.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679478272","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679478272?lang=zh_cn&edition=full","pubTime":"2026-10-29 16:34","pubTimestamp":1793262847,"startTime":"0","endTime":"0","summary":"智通财经APP讯,方达控股(01521)发布公告,集团截至2026年9月30日止九个月的收益约为2.31亿美元,较2025年同期增加20.9%。集团于截至2026年9月30日止九个月取得纯利约1190万美元,较2025年同期增加113.1%。经扣除以股份为基础的薪酬开支、并购所得无形资产摊销、按公允价值计入损益计量的金融资产所产生的收益或亏损、重组及资源整合举措产生的亏损及并购相关开支后,集团截至2026年9月30日止九个月的经调整纯利约为2060万美元,较2025年同期增加62.7%。于2026年9月30日,集团的未经审核综合资产净值约为3.63亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1515053.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","BK1583","BK1141","01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677980564","title":"泰格医药(300347.SZ)控股子公司方达控股(01521)停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2677980564","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677980564?lang=zh_cn&edition=full","pubTime":"2026-10-22 11:52","pubTimestamp":1792641147,"startTime":"0","endTime":"0","summary":"智通财经APP讯,泰格医药(300347.SZ)发布公告,公司下属控股子公司Frontage Holdings Corporation(以下简称“方达控股”,股票代码:01521.HK)为香港联合交易所有限公司(以下简称“香港联交所”)上市公司。根据香港联交所证券上市规则等相关规定,方达控股于2026年10月22日在香港联交所网站发布了《短暂停牌》公告。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1510593.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1576","BK0077","BK1583","BK0028","300347","03347","BK0216","BK0174","01521","BK1141","LU1146622755.USD","LU1820825898.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194268545","title":"方达控股(01521)10月22日起短暂停牌 待刊发收购及合并守则相关内幕消息","url":"https://stock-news.laohu8.com/highlight/detail?id=1194268545","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194268545?lang=zh_cn&edition=full","pubTime":"2026-10-22 08:56","pubTimestamp":1792630571,"startTime":"0","endTime":"0","summary":"方达控股(01521)10月22日公告称,应公司要求,其股份已自2026年10月22日上午9时正起在香港联合交易所有限公司短暂停止买卖。公司表示,是次停牌旨在待根据《公司收购及合并守则》刊发载有公司内幕消息的公告。\n截至本公告日期,方达控股董事会成员包括:执行董事李松博士、Wentao Zhang博士及Zhongping Lin博士;非执行董事Zhuan Yin女士及吴灝先生;独立非执行董事李轶梵先生、刘二飞先生及王劲松博士。\n公司将另行刊发相关内幕消息公告。投资者可留意后续披露,以获取进一步信息。\n公告由方达控股董事会主席李松博士代表董事会发布,日期为2026年10月22日。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677989544","title":"方达控股(01521.HK)10月22日起短暂停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2677989544","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677989544?lang=zh_cn&edition=full","pubTime":"2026-10-22 08:51","pubTimestamp":1792630260,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1576","BK1141","01521","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677895429","title":"方达控股(01521)10月22日起短暂停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2677895429","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677895429?lang=zh_cn&edition=full","pubTime":"2026-10-22 08:51","pubTimestamp":1792630260,"startTime":"0","endTime":"0","summary":"智通财经APP讯,方达控股(01521)发布公告,公司股份将于2026年10月22日上午九时正起短暂停止买卖。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1510504.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01521","BK1141","BK1583","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677985207","title":"泰格医药(03347):方达控股10月22日起短暂停牌 待刊发内幕消息","url":"https://stock-news.laohu8.com/highlight/detail?id=2677985207","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677985207?lang=zh_cn&edition=full","pubTime":"2026-10-22 08:07","pubTimestamp":1792627636,"startTime":"0","endTime":"0","summary":"智通财经APP讯,泰格医药(03347)发布公告,公司留意到,公司的附属公司方达控股(01521.HK)的股份已于2026年10月22日上午9时正起在香港联合交易所有限公司短暂停止买卖,以待方达控股根据公司收购及合并守则发出载有方达控股内幕消息的公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1510475.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0077","LU1146622755.USD","BK1576","03347","LU1820825898.SGD","BK0216","BK1141","300347","01521","BK0028","BK0174","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149311793","title":"港股直击|医药股及医药外包股续上扬,方达控股升 7%,歌礼制药、云顶新耀、金斯瑞生物升6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1149311793","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149311793?lang=zh_cn&edition=full","pubTime":"2026-10-21 09:54","pubTimestamp":1792547682,"startTime":"0","endTime":"0","summary":"医药股及医药外包股续上扬,方达控股升 7%,歌礼制药、云顶新耀升、金斯瑞生物 6%,再鼎医药、心玮医疗、康希诺生物升 4%。","market":"hk","thumbnail":"https://static.tigerbbs.com/d17cb0ea313437e7afb8bad7f25dce9a","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/d17cb0ea313437e7afb8bad7f25dce9a"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","01952","01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162803487","title":"港股直击|医药股及医药外包股上扬,方达控股升9%,昭衍新药升7%,康诺亚、华领医药升4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1162803487","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1162803487?lang=zh_cn&edition=full","pubTime":"2026-10-20 11:02","pubTimestamp":1792465344,"startTime":"0","endTime":"0","summary":"医药股及医药外包股上扬,方达控股升 9%,昭衍新药升 7%,康诺亚、华领医药、亚盛医药升 4%。","market":"hk","thumbnail":"https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02162","02552","06127","01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195988661","title":"方达控股2026年9月股本结构保持稳定,未现新增发行","url":"https://stock-news.laohu8.com/highlight/detail?id=1195988661","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195988661?lang=zh_cn&edition=full","pubTime":"2026-10-06 16:37","pubTimestamp":1791275866,"startTime":"0","endTime":"0","summary":"方达控股于2026年10月6日公布截至2026年9月30日止月份证券变动月报。公告显示,公司法定股本为5,000,000,000股普通股,面值为每股0.00001美元,法定股本总额50,000美元,与上月持平。截至2026年9月底,公司已发行股份数量为2,042,074,910股,与上月底保持相同,库存股数量则为0股。月内无新增发行及回购活动,整体股本结构维持不变。公司同时确认,所有本月涉及的股份事宜均已按适用上市规则、法律及其他规定进行。本次公告由执行董事兼主席李松签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164893441","title":"方达控股2026年中期营收1.48亿美元,经调整净利润0.13亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1164893441","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164893441?lang=zh_cn&edition=full","pubTime":"2026-09-22 16:38","pubTimestamp":1790066300,"startTime":"0","endTime":"0","summary":"方达控股于2026年上半年实现营收约1.48亿美元,同比增长17.1%。经调整净利润约0.13亿美元,同比大幅增长74%。报告期内,毛利率由上年同期的27.9%降至25.6%。经调整的税息折旧及摊销前利润为3450万美元,同比增长22.8%,经营活动产生的现金流净额为2566万美元,同比增长36.7%。报告期内,研发投入占总营收的比重约为2.05%,较上一年同期有所提升。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"方达控股2026年中期营收1.48亿美元,经调整净利润0.13亿美元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150022602","title":"方达控股更新8月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1150022602","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1150022602?lang=zh_cn&edition=full","pubTime":"2026-09-04 16:48","pubTimestamp":1788511729,"startTime":"0","endTime":"0","summary":"方达控股于2026年9月4日公布截至2026年8月31日的股份变动月报表。公告显示,公司注册股本保持为5,000,000,000股普通股,面值每股0.00001美元,注册股本合计50,000美元;已发行股份维持2,042,074,910股,与上月末持平,公众持股量符合相关监管规定。根据报告期内披露信息,公司未有新增股份发行,亦无正式注销股份。截至2026年8月31日,公司股本总数保持稳定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662506653","title":"方达控股(01521.HK)发布中期业绩 股东应占溢利675.5万美元 同比增加130.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662506653","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662506653?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:46","pubTimestamp":1787910379,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1141","BK1576","01521","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662066866","title":"方达控股:上半财年净利润同比增长134.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662066866","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662066866?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:40","pubTimestamp":1787910000,"startTime":"0","endTime":"0","summary":"南财智讯8月28日电,方达控股(01521.HK)公告,截至2026年6月30日止六个月,公司实现收益148200000.00美元,同比增长17.05%;净利润6800000.00美元,同比增长134.50%;每股基本盈利0.0033美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608283858301783.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608283858301783.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161239129","title":"方达控股(01521)2026年上半年营收1.48亿美元,经调整净利润13.4百万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1161239129","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161239129?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:39","pubTimestamp":1787909995,"startTime":"0","endTime":"0","summary":"方达控股公告显示,截至2026年6月30日止六个月,营收为148.2百万美元,同比增长17.1%,折合约1.48亿美元。经调整净利润由上年同期的7.7百万美元增长至13.4百万美元,增幅74.0%。报告期内,经调整税息折旧及摊销前利润为34.5百万美元,同比上升22.8%,对应经调整利润率提升至23.3%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"方达控股(01521)2026年上半年营收1.48亿美元,经调整净利润13.4百万美元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660419923","title":"CXO概念有支撑 凯莱英(06821)涨2.27% 金斯瑞生物科技(01548)涨2.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660419923","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660419923?lang=zh_cn&edition=full","pubTime":"2026-08-19 10:53","pubTimestamp":1787108028,"startTime":"0","endTime":"0","summary":"金吾财讯 | CCXO概念有支撑,凯莱英 涨2.27%、金斯瑞生物科技涨2.41%、百济神州涨0.63%、方达控股涨0.79%、药明生物涨0.04%爱建证券表示,2026年初以来医药板块的持续回调与行业基本面、产业趋势发生背离,近期众多上市公司推出现金回购和增持方案,反映出对产业未来发展的充足信心,CXO、创新药及相关产业链已率先发力反弹,医药板块中长期布局良机已至。同时,该机构看好高景气CXO、器械出海、脑机接口、AI+医疗等投资机会。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1988641","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160","HK0000306685.HKD","01521","BK1141","LU0320764599.SGD","002821","LU0228659784.USD","LU0043850808.USD","LU0819121731.USD","LU0039217434.USD","HK0000320223.HKD","06821","CXO","BK1576","LU0140636845.USD","SG9999002463.SGD","02269","BK1610","LU0359202008.SGD","LU1242518931.SGD","BK0239","LU1719994722.HKD","LU1720050803.USD","LU0128526141.USD","BK1191","LU0181495838.USD","BK1589","WX","LU0516422366.SGD","LU0417516738.SGD","LU0456827905.SGD","LU3063872942.SGD","LU0588546209.SGD","BK1500","LU0708995583.HKD","LU0828237510.HKD","BK1588","LU0417516902.SGD","LU0516423091.SGD","LU0052750758.USD","LU0572944931.SGD","LU0359201612.USD","LU0516422440.USD","01548","LU1770034418.SGD","LU2328871848.SGD","LU1969619763.USD","LU1688375341.USD","LU0348825331.USD","KURE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189298286","title":"方达控股(01521)拟于8月28日召开董事会审议2026年中期业绩及派息事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=1189298286","media":"公告速递","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189298286?lang=zh_cn&edition=full","pubTime":"2026-08-17 16:36","pubTimestamp":1786955793,"startTime":"0","endTime":"0","summary":"方达控股(01521)8月17日公告称,公司董事会已排定于2026年8月28日(星期五)举行会议,议程包括:一、审议及通过公司及其附属公司截至2026年6月30日止六个月的中期业绩;二、研究及考虑派发中期股息(如有)。\\n\\n公告显示,目前董事会成员包括:执行董事李松博士(主席)、Wentao Zhang博士及Zhongping Lin博士;非执行董事Yin Zhuan女士及吴灏先生;独立非执行董事李轶梵先生、刘二飞先生及王劲松博士。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164917111","title":"方达控股更新2026年6月股份变动月报表:总股本增至2,042,074,910股","url":"https://stock-news.laohu8.com/highlight/detail?id=1164917111","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164917111?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:36","pubTimestamp":1786523803,"startTime":"0","endTime":"0","summary":"方达控股公司于2026年8月12日披露2026年6月股份变动月报表。公告显示,截至2026年6月30日,公司法定/注册股本保持在5,000,000,000股,股份每股面值为0.00001美元,总额为50,000美元。此外,2018年股份激励计划项下本月取消1,209,000股期权、失效461,000股,期末结存73,882,000股期权。公告提及,公司此前于2024年5月28日购回3,536,000股普通股,相关股份拟进行注销但截至本报告期末尚未完成注销。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658609113","title":"医药外包概念股集体扬升 药明生物(02269)涨4.36% 机构指行业景气度上行信号明确","url":"https://stock-news.laohu8.com/highlight/detail?id=2658609113","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658609113?lang=zh_cn&edition=full","pubTime":"2026-08-10 09:58","pubTimestamp":1786327110,"startTime":"0","endTime":"0","summary":"消息面上,国金证券发布研报指,CXO行业已完整经历一轮产业周期,当下行业景气度上行信号明确。目前,随着外部压力缓释、全球投融资回暖,国内BD持续升温,行业已进入内外需共振、新分子赛道放量、订单与业绩逐季改善的新一轮复苏上行周期。展望2026年,海外头部CXO企业收入指引仍维持稳健小幅增长格局,叠加全球生物医药投融资逐步回暖、创新药研发需求稳步复苏,行业景气度延续上行态势,成长确定性进一步增强。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987777","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU3063872942.SGD","BK1521","BK1576","LU0708995583.HKD","LU0516423174.USD","LU0052750758.USD","LU0307460666.USD","LU1242518931.SGD","06127","01873","BK1574","LU0572944931.SGD","LU0051755006.USD","HK0000306701.USD","LU0819121731.USD","LU1880383366.USD","159938","LU1242518857.USD","LU2242644610.SGD","BK1161","LU1046422090.SGD","KURE","BK1191","SG9999002562.SGD","LU0588546209.SGD","BK1141","LU0823426308.USD","02359","09939","01548","LU0417516738.SGD","LU0456827905.SGD","LU0320764599.SGD","LU0516422366.SGD","LU0979878070.USD","02269","IE00B0JY6N72.USD","LU0043850808.USD","LU0181495838.USD","LU2039709279.SGD","LU2125910500.SGD","LU1720050803.USD","LU0140636845.USD","01521","06821","LU0823426480.USD","BK1515","BK1589","LU0348767384.USD","HK0000320264.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.frontagelab.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.2957},{"period":"3month","weight":0.1462},{"period":"6month","weight":0.5051},{"period":"1year","weight":0.3423},{"period":"ytd","weight":0.49}],"compareEarnings":[{"period":"1week","weight":0.051},{"period":"1month","weight":0.0146},{"period":"3month","weight":-0.0462},{"period":"6month","weight":-0.0724},{"period":"1year","weight":-0.0757},{"period":"ytd","weight":-0.0448}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"Frontage Holdings Corp是一家控股公司。该公司为制药和农用化学品公司提供实验室和相关服务,以及生物等效性临床和化学服务。该公司有两个分部。全球实验室服务部门为参与药物开发的客户提供实验室测试支持。全球药物发现与开发服务部门包括药物开发部门、药物发现部门和药品开发部门。其全球实验室服务涵盖受监管和非受监管的生物分析(小分子和大分子)、生物标志物、基因组学、制造和控制分析测试以及中央实验室服务。药物开发部门包括药物代谢和药代动力学、安全性和毒理学。该公司的业务分部包括北美和欧洲以及中国。","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.028193},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.020831},{"month":3,"riseRate":0,"avgChangeRate":-0.123558},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.028258},{"month":5,"riseRate":0.428571,"avgChangeRate":0.000234},{"month":6,"riseRate":0.5,"avgChangeRate":0.064223},{"month":7,"riseRate":0.5,"avgChangeRate":0.02413},{"month":8,"riseRate":0.375,"avgChangeRate":-0.041995},{"month":9,"riseRate":0.25,"avgChangeRate":0.014024},{"month":10,"riseRate":0.25,"avgChangeRate":-0.000779},{"month":11,"riseRate":0.5,"avgChangeRate":0.080076},{"month":12,"riseRate":0.714286,"avgChangeRate":0.124365}],"exchange":"SEHK","name":"方达控股","nameEN":"FRONTAGE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"方达控股(01521)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供方达控股(01521)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"方达控股,01521,方达控股股票,方达控股股票老虎,方达控股股票老虎国际,方达控股行情,方达控股股票行情,方达控股股价,方达控股股市,方达控股股票价格,方达控股股票交易,方达控股股票购买,方达控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"方达控股(01521)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供方达控股(01521)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}